First patient dosed in Bexion cancer drug trial
The trial is being conducted at CTI Clinical Research Center in Cincinnati. The plan is to enroll 20 patients.
David Holthaus's Latest Articles
Contest winners for the region’s most photogenic bridge
The 2022 photo contest received a record number of submissions with separate entries for amateur and professional photographers.
BLINK 2022 will light up Northern Kentucky
Covington will be one of five walkable BLINK zones, with the others in Cincinnati: The Findlay Market neighborhood, Over-the-Rhine, The Banks, and Downtown.
New EV charging stations installed at Prysmian Group’s headquarters
“It is ... almost like the company giving you a half tank of gas to come to work,” says employee James McGraw.
Celebrating the people and music of Cincinnati jazz
The Jazz Hall of Fame honors contributors to the art form and to further jazz education through scholarships and mentoring.
A City Safe to Walk In: Neighborhood action and Vision Zero aim to make the streets safer
City neighborhoods are prized for walkability and density, but increasingly, getting around on foot or by bike takes nerves of steel. Neighbors work with City Hall for change.
Beech Acres moves back to the urban core
A new centralized location allows nonprofit to connect with more children and families throughout the entire tri-state.
Made in Camp features the artisans of Camp Washington
This small neighborhood is still a place where people make things, as it’s become a growing haven for artists.
Senior research scientist works with undergrads at Wood Hudson cancer lab
Dr. Erik Arnold Bey’s resume includes training and experience in cell and molecular biology, cancer biology, drug delivery, and nanomedicine.
Newport Aquarium’s research on shark rays is shared worldwide
Its work has helped teach scientists around the globe about the endangered species.
